ArticleFrontiers in endocrinology2022

Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy.

Youngsook Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.